As of this writing producing a Who's On First -enabled Protomaps tile database is a manual two-step process. The first step is to produce a line-separated feed of GeoJSON files. The second step is to ...

Credit: MacroEcon/Shutterstock. Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with cerebrotendinous xanthomatosis (CTX), a ...

Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form of lipid storage disease. Ctexli (chenodiol) has been cleared to treat ...

The approval is based on data from the Phase 3 RESTORE study evaluating the safety and efficacy of CTEXLI in adult patients with CTX by measurement of urine bile alcohols and other secondary measures.

static ngx_int_t ngx_rtmp_relay_init_process(ngx_cycle_t *cycle); static ngx_int_t ngx_rtmp_relay_postconfiguration(ngx_conf_t *cf); static void * ngx_rtmp_relay ...

A look at the day ahead in European and global markets from Rae Wee ...

The Ducks (24-9) will open against No. 12 seed Liberty (28-6) in the first round of the East Region in the NCAA Tournament on ...

Recommended testing includes a very long chain fatty acid (VLCFA) profile in men (ALD), specific white cell enzyme activities (Krabbe disease, MLD), raised serum cholestanol/urinary bile alcohols ...

The FDA on Friday gave the green light to Mirum’s Ctexli, also known as chenodiol, for the treatment of adults with cerebrotendinous xanthomatosis (CTX). The approval makes chenodiol—already ...

SILVER SPRING, Md., Feb. 21, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli ...

Conference call details: Wednesday, February 26, 2025 4:30 p.m. ET / 1:30 p.m. PT Dial-in: U.S./Toll-Free: + 1 833 470 1428 International: + 1 404 975 4839 Passcode: 126145 You may also access the ...